Invicta Diagnostic Board of Directors

Get the latest insights into the leadership at Invicta Diagnostic. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Sanket Vinod Jain Chairman & Non-Exe.Director
Dr. Ketan Jayantilal Jain Non Executive Director
Mr. Aayush Kamleshbhai Shah Independent Director
Mr. Shilpa Ajay Bhatia Independent Director

Invicta Diagnostic Share price

INVICTA

65

1.90 (-2.84%)
Last updated on 20 Feb, 2026 | 15:13 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

66.00

Today's Low

65.00

52 Week Low

60.20

52 Week High

105.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Invicta Diagnostic FAQs

The board at Invicta Diagnostic consists of experienced professionals, including Dr. Sanket Vinod Jain , Dr. Ketan Jayantilal Jain , and others, overseeing the company’s strategic and corporate governance.

Directors at Invicta Diagnostic are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Sanket Vinod Jain is the current chairman at Invicta Diagnostic.

Executive directors at Invicta Diagnostic are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Invicta Diagnostic adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Invicta Diagnostic, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost